Our Top Picks
- Best Overall: Dexcom G7 offers the most seamless ecosystem with direct-to-watch connectivity and a highly reliable 15.5-day wear window.
- Best Value: FreeStyle Libre 3 Plus delivers the smallest form factor on the market and the most competitive pricing for those paying out-of-pocket.
- Best for Longevity: Eversense 365 eliminates weekly sensor changes with a single subcutaneous implant that lasts a full calendar year.
- Best for Biohacking: Dexcom Stelo provides an accessible, over-the-counter gateway for non-insulin users to optimize metabolic health.
The best continuous glucose monitors in 2026 include the Dexcom G7, known for its 15.5-day wear time and high accuracy, and the Abbott FreeStyle Libre 3 Plus, which is the world's smallest sensor with a 15-day wear period. For those seeking long-term tracking, the Eversense 365 is the first implantable CGM designed to last a full year. Users with type 2 diabetes not on insulin may also consider over-the-counter options like the Dexcom Stelo.
Understanding Accuracy: MARD and iCGM Standards
In the world of functional health and longevity, data is only as good as its reliability. When we evaluate the best continuous glucose monitors, we look at the Mean Absolute Relative Difference, or MARD. This is the industry standard for measuring device accuracy. In simple terms, a lower MARD percentage indicates that the sensor readings are closer to a laboratory blood test. For context, the FreeStyle Libre 3 has achieved a score of 7.9% in adult clinical studies, while the Dexcom G7 typically reports a MARD of around 8.2%.
It is also important to understand the regulatory landscape. Devices labeled as iCGM (integrated Continuous Glucose Monitoring) meet rigorous standards that allow them to communicate with other compatible medical devices, such as automated insulin pumps. These sensors measure glucose levels in the interstitial fluid—the fluid surrounding your cells—rather than directly in the bloodstream. Because there is a slight physiological lag between blood glucose and interstitial fluid, modern calibration-free sensors use advanced algorithms to provide real-time telemetry that mimics blood levels with remarkable precision.
The market for these devices is expanding rapidly. The global market for continuous glucose monitors was valued at $13.28 billion in 2025 and is projected to reach $31.38 billion by 2031. This growth is driven by both clinical need and a surging interest in metabolic health tracking among the general population. Currently, the market is highly concentrated, with Abbott, Dexcom, and Medtronic collectively controlling approximately 98.8% of total industry revenue.
The Heavyweights: Dexcom G7 vs. FreeStyle Libre 3 Plus
The competition between Dexcom and Abbott has pushed wearable technology to its limits. In any cgm device comparison 2026, these two models dominate the conversation. The Dexcom G7 has become a favorite for its 30-minute warm-up period and its ability to send alerts directly to an Apple Watch without needing a phone nearby. Conversely, the FreeStyle Libre 3 Plus is celebrated for being the world's smallest and most discreet continuous glucose monitors for active lifestyles, roughly the size of two stacked pennies.
| Feature | Dexcom G7 | FreeStyle Libre 3 Plus |
|---|---|---|
| Wear Time | 10 days (+ 12-hour grace period) | 15 days |
| MARD Accuracy | 8.2% | 7.9% - 8.2% |
| Warm-up Time | 30 Minutes | 60 Minutes |
| Connectivity | Direct-to-Watch, Smartphone | Smartphone, Selected Pumps |
| Calibration | Factory Calibrated (No Fingersticks) | Factory Calibrated (No Fingersticks) |
Dexcom G7
- Pros: Fastest warm-up in the industry; exceptional smartphone and Apple Watch integration; 12-hour grace period for sensor changes.
- Cons: Slightly larger profile than the Libre; higher price point without insurance.
FreeStyle Libre 3 Plus
- Pros: Smallest and most discreet wearable; 15-day wear time; generally the most affordable option.
- Cons: Does not offer a grace period once the 15 days are up; faced a limited sensor recall in early 2026 which required users to check serial numbers for potential inaccuracies.
When looking at wearable glucose monitoring software features, both brands offer robust apps that provide glucose trend arrows and time-in-range data. These insights are vital for understanding how specific foods or stressors impact your physiology in real-time.
Long-Term Tracking: The Eversense 365 Breakthrough
For many, the biggest friction point of continuous glucose monitoring is the weekly or bi-weekly ritual of applying a new sensor. The Eversense 365 has changed the game by offering the first implantable sensor designed to last an entire year. Unlike the transcutaneous application of the Dexcom or Libre, which uses a small cannula under the skin, the Eversense is a tiny, pill-sized sensor placed under the skin of the upper arm by a healthcare professional.
When conducting an eversense 365 vs dexcom g7 for long term tracking analysis, the primary trade-off is convenience versus invasiveness. While the G7 is a DIY application, the Eversense requires a quick in-office procedure. However, for the following 365 days, the user only needs to wear a removable transmitter over the site. This transmitter can be taken off for swimming or contact sports without wasting a sensor. For those who want continuous glucose monitor sensor accuracy comparison 2026 data, the Eversense 365 holds its own with a MARD of approximately 8.5%, making it a highly reliable long-term solution for adults who want to minimize daily maintenance.
Beyond Prescription: OTC CGM for Metabolic Health
One of the most exciting shifts in 2026 is the mainstreaming of over-the-counter (OTC) options. The Dexcom Stelo is the best over-the-counter cgm for type 2 diabetes tracking for those not using insulin, but it has also gained massive traction in the biohacking community. Because it does not require a prescription, it has opened the doors for individuals interested in preventative health and metabolic optimization.
These OTC devices focus heavily on time-in-range and the impact of lifestyle choices rather than high-frequency hypoglycemia alerts required by Type 1 patients. By integrating with platforms like Oura, Whoop, and Apple Health, the Stelo allows users to see how a late-night meal or a high-intensity workout affects their glucose stability. This shift toward metabolic health tracking represents the projected 15.42% compound annual growth rate we are seeing in the broader CGM market.
Budget and Accessibility: Finding the Lowest Cost in 2026
Affordability remains a significant hurdle for many. While insurance often covers CGM for insulin-dependent users, those using them for general health often pay out-of-pocket. Currently, the most affordable continuous glucose monitors without insurance 2026 are found within the Abbott FreeStyle Libre family. Without insurance, a monthly supply of Libre 3 Plus sensors typically ranges from $75 to $150, depending on the pharmacy and available coupons.
Dexcom has countered this with their Stelo subscription model, priced around $89 per month, making it a competitive choice for the health-conscious consumer. For those with high-deductible health plans, remember that these devices are typically HSA and FSA eligible. Always check for manufacturer patient assistance programs, which can significantly lower the barrier to entry for high-end continuous glucose monitor sensor accuracy.
FAQ
What is the most accurate continuous glucose monitor?
The most accurate monitors are generally considered to be the Dexcom G7 and the FreeStyle Libre 3 Plus. Both devices boast MARD scores in the 7.9% to 8.2% range. Accuracy can vary slightly based on the sensor's placement and individual physiology, but these two models currently represent the gold standard for consumer-available wearable technology.
Can you get a continuous glucose monitor without a prescription?
Yes, as of 2026, you can obtain certain models like the Dexcom Stelo over-the-counter without a prescription. These are specifically marketed toward non-insulin-using Type 2 diabetics and health-conscious individuals. However, higher-end models like the Dexcom G7 and the Libre 3 Plus still generally require a prescription from a healthcare provider in most regions.
How much do continuous glucose monitors cost per month?
The cost varies based on insurance coverage and the specific device. Out-of-pocket costs typically range from $75 to $160 per month. The FreeStyle Libre 3 Plus is often the most budget-friendly option, while premium systems or implantable sensors like the Eversense 365 involve different cost structures, including professional insertion fees.
Can non-diabetics use continuous glucose monitors for health and fitness?
Absolutely. Many athletes and longevity enthusiasts use CGMs to monitor their metabolic response to different foods, exercise routines, and sleep patterns. By tracking time-in-range and glucose variability, non-diabetics can optimize their energy levels and potentially reduce the risk of developing metabolic disorders later in life.
How long does a CGM sensor last before it needs to be replaced?
Most modern transcutaneous sensors last between 10 and 15 days. The Dexcom G7 lasts 10 days plus a 12-hour grace period, while the FreeStyle Libre 3 Plus lasts a full 15 days. The exception is the Eversense 365, which is an implantable sensor that remains functional for an entire year before needing a replacement procedure.
Choosing the Right CGM for Your Lifestyle
Selecting the right device depends entirely on your primary goal. If you are an athlete who needs cgm with best apple watch and smartphone integration to monitor fuel levels during a marathon, the Dexcom G7 is your best bet. Its real-time telemetry and rapid warm-up period make it indispensable for high-performance environments.
For the busy professional who wants a "set-it-and-forget-it" metabolic health tool, the FreeStyle Libre 3 Plus offers the best balance of discretion and price. And if you are someone who finds the weekly sensor changes burdensome, the Eversense 365 provides unparalleled freedom. Regardless of which path you choose, the data provided by these continuous glucose monitors is a powerful catalyst for long-term health and functional longevity.
